back to conferences
EU Simoa® Success Seminar: Lisbon
date
October 3-4, 2023location
Lisbon, PortugalOctober 3rd – 4th, 2023 | Hyatt Regency Lisbon, R. da Junqueira 65, 1300-343 Lisbon, Portugal
Optimize your Simoa® experience!
Connect with accomplished users of our ultrasensitive Simoa® technology and learn about assay development, Simoa® best practices, and more.
Join us for technical presentations from Quanterix and Simoa® users, workshops, Simoa® users poster session, and networking opportunities. Agenda is listed below.
| Day 1: Tuesday, 3rd October | Moderator: Danilo La Terra, Senior Field Application Scientist, Quanterix | |
| 13.45-14.00 | Registration |
| 14.00-14.10 | Opening remarks Milena Milutinovic PhD, Senior Manager Field Applications, Quanterix |
| 14.10-14.40 | Scaling up Simoa®: Preparing for large kit projects Lindsey Marsh PhD, Senior Field Application Scientist, Quanterix |
| 14.40-15.10 | High sensitivity phenotyping of extracellular vesicles Alessandro Gori PhD, National Research Council of Italy (SCITEC-CNR) |
| 15.10-15.40 | A CROs guide to homebrewing success: Awkward antibodies & sensitive solutions Daniel Creed, Senior Scientist, Resolian, UK |
| 15.40-16.10 | Coffee break |
| 16.10-16.40 | Simoa data analysis Victor Liman, Manager Technical Applications, Quanterix |
| 16.40-17.10 | Quanterix service overview and qualification tips & tricks Quanterix Service Team |
| 17.10-17.40 | Poster session |
| 19h | Dinner |
| Day 2: Wednesday, 4th October | Moderator: Ilaria Mancini, Field Application Scientist, Quanterix | |
| 9.00-9.30 | LucentAD and Quanterix’s diagnostic strategy Zachary Fernandes, Director, Global Channel Strategy, Quanterix |
| 9.30-10.00 | The new normal – Detecting Alzheimer’s disease pathology through blood tests Hanna Huber PhD, Neurochemistry department at the University of Gothenburg, Sweden |
| 10.00-10.30 | NfL reflects neuron damage in in vitro models of acute brain injury Massimiliano De Paola PhD, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy |
| 10.30-11.15 | Coffee break |
| 11.15-11.30 | Simoa® in oncology: Now and in future Byron Shen PhD, Director, Oncology Business Development, Quanterix |
| 11.30-11.45 | Translational Simoa® sensitivity blood-based biomarkers for neurological drug development and clinical trial support Mark Roskey PhD, Chief Science and Collaboration Officer, Quanterix |
| 11.45-12.30 | Simoa® Best practices, Open Discussion:Group A) HD-X, B) SR-X, C) SP-X |
| 12.30-12.45 | Closing remarks Milena Milutinovic PhD, Senior Manager Field Applications, Quanterix |